Renaissance Capital logo

MAIA News

US IPO Weekly Recap: Small deals continue to dominate the summer IPO calendar

MAIA

Four deals priced this past week, only two of which met the criteria to be included in our 2022 IPO stats. Biotech MAIA Biotechnology (MAIA) offered more shares and priced at the low end to raise $10 million at a $68 million market cap....read more

Renaissance Capital’s July IPO Market Update

MAIA Biotechnology logo

Seven IPOs raised a combined $228 million in the slowest July in what’s shaping up to be ...read more

Cancer biotech MAIA Biotechnology prices IPO at $5 low end

MAIA Biotechnology logo

MAIA Biotechnology, a Phase 2 biotech developing targeted immunotherapies for cancer, raised $10 million by offering 2 million shares at $5, the low end of the range of $5 to $7. The company offered 0.3 million more shares than anticipated. The company's lead...read more

US IPO Week Ahead: 2 small IPOs bring esports and cancer immunotherapies to market

MGAM

Two small deals are scheduled to price in the week ahead as the IPO market stays on track to post ...read more